Medtronic CEO Omar Ishrak has long turned to emerging markets as a potential growth driver, and tapping into India's burgeoning population will play a key role in ramping up the company's business there, he said.
Medtronic is touting positive study results for its antibacterial envelope in high-risk patients who undergo cardiac device implantation, a feather in the company's cap as it continues to forge ahead with the innovative technology.
Medtronic touted data on its investigational, MRI-safe implantable defibrillator and leadless pacemaker presented at the Heart Rhythm Society's annual meeting in Boston.
Medtronic's Covidien was hit with a recall of 1,661 units of its VenaSeal Sapheon Closure System, a procedural delivery system for an adhesive that treats venous reflux disease by closing the affected veins in the lower leg.
Medtronic announced concurrent FDA and CE-mark approval of the latest generation of its stroke-fighting Arctic Front Advance ST Cryoablation Catheter. The device features a shorter tip designed to help physicians visualize the procedure in real time and enable increased maneuverability of the device.
The FDA granted its stringent PMA approval to Medtronic's surgically implanted Model 5071 Lead for use in conjunction with cardiology devices like pacemakers, defibrillators and CRT-Ds, which combine the benefits of pacemakers and defibrillation therapy.
The world's smallest cardiac monitor implant is on track to make a move into the doctor's office. Medtronic's aim is to further capitalize upon a hugely successful launch of its Reveal Linq that's already exceeded all expectations with a potential for drug-like blockbuster annual sales of $1 billion to $2 billion.
Intraoperative imaging is at the forefront of advances in surgery, as researchers and engineers discover new uses of old technologies like MRIs and CT scans, which can now be used to guide physicians during surgery in real time.
Medtronic announced that enrollment is underway on an atrial fibrillation trial involving a trio of its devices: the Arctic Front Advance Cryoballoon for ablating heart tissue, Symplicity Spyral Catheter for delivering renal denervation to fight high cholesterol, and Reveal Linq insertable cardiac monitor.
The FDA halted the manufacture of Medtronic's SynchroMed II Implantable Infusion Pump Systems, citing repeatedly failing to correct violations of the agency's quality system regulations in a consent decree filed against company CEO Omar Ishrak and Senior Vice President Thomas Tefft.